Herpes zoster
☆ AI Dermatology — Free Service
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Herpes zoster
relevance score : -100.0%
ReferencesHerpes zoster (shingles), ex reactivatione virus varicellae zoster responsabilis pro varicella (chickenpox), circa 1 million hominum annuatim in Civitatibus Foederatis afficit, cum periculo vitae 30 %. In immunitate debilitata signanter magis proniores sunt ad graves casus, cum signis typicis incipientibus malaise, capitis dolore, et febre levia, sequuntur sensus cutanei insoliti paucis diebus ante rash (herpes zoster rash) apparens. Rash (herpes zoster rash), plerumque in specifica corporis parte apparens, progreditur e pustulis perspicuis ad ulcera contrita per hebdomadem ad decem dies. Curatio prompta cum medicamentis antiviralibus (acyclovir, valacyclovir, famciclovir) intra 72 horas a rash initio crucialis est. Neuralgia postherpetica, communis complicatio, quae diuturno dolore in area affectata est, circa unum in quinque aegros afficit et cum medicamentis permanentem administrationem requirit ut gabapentin (gabapentin), pregabalin (pregabalin), vel antidepressoria quorundam, una cum agentibus topicis sicut lidocaine (lidocaine) vel capsaicin (capsaicin). Vaccinatio contra virus varicellae zoster commendatur pro adultis annorum 50 et supra ad periculum herpes zoster reducendum.
Shingles, caused by the reactivation of the varicella zoster virus responsible for chickenpox, affects around 1 million people annually in the United States, with a lifetime risk of 30%. Those with weakened immune systems are significantly more prone to developing shingles, with symptoms typically starting with malaise, headache, and a mild fever, followed by unusual skin sensations a few days before the appearance of a rash. This rash, usually appearing in a specific area of the body, progresses from clear blisters to crusted sores over a week to ten days. Prompt treatment with antiviral medications (acyclovir, valacyclovir, or famciclovir) within 72 hours of rash onset is crucial. Postherpetic neuralgia, a common complication characterized by prolonged pain in the affected area, affects about one in five patients and requires ongoing management with medications such as gabapentin, pregabalin, or certain antidepressants, along with topical agents like lidocaine or capsaicin. Vaccination against the varicella zoster virus is recommended for adults aged 50 and above to reduce the risk of shingles.
Shingles, caused by the reactivation of the varicella zoster virus responsible for chickenpox, affects around 1 million people annually in the United States, with a lifetime risk of 30%. Those with weakened immune systems are significantly more prone to developing shingles, with symptoms typically starting with malaise, headache, and a mild fever, followed by unusual skin sensations a few days before the appearance of a rash. This rash, usually appearing in a specific area of the body, progresses from clear blisters to crusted sores over a week to ten days. Prompt treatment with antiviral medications (acyclovir, valacyclovir, or famciclovir) within 72 hours of rash onset is crucial. Postherpetic neuralgia, a common complication characterized by prolonged pain in the affected area, affects about one in five patients and requires ongoing management with medications such as gabapentin, pregabalin, or certain antidepressants, along with topical agents like lidocaine or capsaicin. Vaccination against the varicella zoster virus is recommended for adults aged 50 and above to reduce the risk of shingles.
Herpes zoster frequentius fieri solet in senioribus quinquaginta et senioribus, qui systemata immunia debilitantur et medicamenta immunosuppressiva capientia. Urguet per reactivationem virus varicellae‑zoster (varicella‑zoster virus), idem virus quod varicella (chickenpox) creat. Signa, sicut febris, dolor, et pruritus, plerumque praecedunt eruptionem propriam. Frequentissima complicatio est neuralgia postherpetica (postherpetic neuralgia), quae est dolor nervi persistens post evagationem eruptionis. Periculum factores et complicationes cum herpes zoster consociata variantur secundum aetatem, valetudinem immunem et initium curationis. Vaccinatio in personis annorum 60 et supra ostensa est ad signanter reducere eventum herpes zoster et neuralgia postherpeticae (postherpetic neuralgia). Incipiens medicamentum antiviralem et analgesicum intra 72 horas eruptionis initium, severitatem et complicationes herpes zoster et neuralgia postherpeticae minuere possunt.
Herpes zoster tends to occur more frequently in people aged 50 and older, those with weakened immune systems, and those taking immunosuppressant medications. It's triggered by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. Symptoms like fever, pain, and itching commonly precede the appearance of the characteristic rash. The most common complication is post-herpetic neuralgia, which is persistent nerve pain after the rash clears up. The risk factors and complications associated with herpes zoster vary depending on age, immune health, and timing of treatment initiation. Vaccination for individuals aged 60 and above has been shown to significantly reduce the occurrence of herpes zoster and post-herpetic neuralgia. Starting antiviral medications and pain relievers within 72 hours of rash onset can lessen the severity and complications of herpes zoster and post-herpetic neuralgia.
Herpes zoster tends to occur more frequently in people aged 50 and older, those with weakened immune systems, and those taking immunosuppressant medications. It's triggered by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. Symptoms like fever, pain, and itching commonly precede the appearance of the characteristic rash. The most common complication is post-herpetic neuralgia, which is persistent nerve pain after the rash clears up. The risk factors and complications associated with herpes zoster vary depending on age, immune health, and timing of treatment initiation. Vaccination for individuals aged 60 and above has been shown to significantly reduce the occurrence of herpes zoster and post-herpetic neuralgia. Starting antiviral medications and pain relievers within 72 hours of rash onset can lessen the severity and complications of herpes zoster and post-herpetic neuralgia.
Probationes clinicae praelicentiae ostendunt efficaciam vaccini vivi zoster inter 50 % et 70 % et vaccini recombinati inter 90 % et 97 %. In studiis realis mundi de efficacitate, cum sequela circiter 10 annorum, data corroboraverunt studia efficacitatis, ostendentes efficaciam vaccini vivi circa 46 % et vaccini recombinati circa 85 %.
The pre-licensure clinical trials show the efficacy of the live zoster vaccine to be between 50 and 70% and for the recombinant vaccine to be higher at 90 to 97%. Real-world effectiveness studies, with a follow-up of approximately 10 years, were reviewed in this article. These data corroborated the efficacy studies, with vaccine effectiveness being 46% and 85% for the live and recombinant vaccines, respectively.
The pre-licensure clinical trials show the efficacy of the live zoster vaccine to be between 50 and 70% and for the recombinant vaccine to be higher at 90 to 97%. Real-world effectiveness studies, with a follow-up of approximately 10 years, were reviewed in this article. These data corroborated the efficacy studies, with vaccine effectiveness being 46% and 85% for the live and recombinant vaccines, respectively.
Varicella, etiam chickenpox appellata, ex infectione initiali cum virus, quae typice in infantia vel adolescentia fit. Postquam varicella resoluta est, virus in cellulis nervorum per annos vel decennia manere potest, antequam reactivetur. Herpes zoster occurrit cum virus varicellae dormiens reactivatur. Inde virus per nervos ad cutem percurrit, pustulas producens. Durante eruptione herpes zoster, exposicio ad virus varicellae in pustulis potest causare chickenpox (varicellam) in aliquo qui numquam hanc morbum habuit.
Factores periculi ad reactivationem virus dormientis includunt senectutem, immunitatem debilitantem, et contrahendam varicellam ante 18 menses aetatis. Virus varicellae‑zoster non idem est ac virus herpes simplex, quamquam uterque ad familiam herpesvirorum pertinet.
Vaccina herpes zoster periculum morbi per 50 % ad 90 % minuunt. Etiam incidenceem neuralgiae postherpeticae decrescunt, et, si herpes zoster occurrit, eius severitatem minuant. Si herpes zoster oritur, medicamenta antiviralia, ut aciclovir, possunt gravitatem et durationem morbi reducere, si intra 72 horas ab initio eruptionis incipient.
○ Curatio
Si laesiones celerius se diffundunt, medicum tuum vide quam primum ad curationem antiviralem.
Utraque medicamenta antiviralia et medicamenta neuralgia requiruntur. Quiescere debes et alcohol vitare.
#Acyclovir
#Famciclovir (Famciclovir)
#Valacyclovir
#Gabapentin
#Pregabalin